Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:498-504

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hendriks, W. L.
Right arrow Articles by Havekes, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hendriks, W. L.
Right arrow Articles by Havekes, L. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:498-504.)
© 1997 American Heart Association, Inc.


Articles

Uptake by J774 Macrophages of Very-Low-Density Lipoproteins Isolated From ApoE-Deficient Mice Is Mediated by a Distinct Receptor and Stimulated by Lipoprotein Lipase

Wendy L. Hendriks; Femke van der Sman-de Beer; Bart J.M. van Vlijmen; Leonie C. van Vark; Marten H. Hofker; ; Louis M. Havekes

From the TNO–Prevention and Health, Gaubius Laboratory (W.L.H., B.J.M. van V., F. van der S.-de B., L.C. van V., L.M.H), and the MGC–Department of Human Genetics, Leiden University (M.H.H.), Leiden, The Netherlands.

Correspondence to Dr L.M. Havekes, TNO–Prevention and Health, Gaubius Laboratory, Zernikedreef 9, 2333 CK Leiden, PO Box 2215, 2301 CE Leiden, The Netherlands. E-mail lm.havekes{at}pg.tno.nl.

Abstract Apolipoprotein (apo) E–deficient mice display marked accumulation in the plasma of VLDL deficient in both apoE and apoB100 but containing apoB48, apoA-I, apoCs, and apoA-IV. Since apoE-deficient mice develop severe atherosclerotic lesions with lipid-laden macrophages, we reasoned that the uptake of lipoproteins by intimal macrophages can take place in the absence of both apoE and apoB100. To get more insight into the mechanism of foam cell formation in apoE-deficient mice, we measured the interaction of VLDL from apoE-deficient mice (apoEnull VLDL) with the murine macrophage cell line J774. Scatchard analysis revealed that apoEnull VLDL is bound to J774 cells with a Kd value comparable to that of control VLDL (8.1 versus 4.7 µg/mL) and with a Bmax value about half that of control VLDL (40 versus 70 ng/mg cell protein, respectively). ApoEnull VLDL is also taken up and degraded by J774 macrophages via a high-affinity process less efficiently than control mouse VLDL (6-fold and 50-fold less efficiently, respectively). In line with this observation, incubation of J774 cells with 50 µg/mL apoEnull VLDL for 24 hours resulted in an increase in intracellular cholesteryl ester (CE) content, although 5-fold less pronounced than after incubation with 50 µg/mL control mouse VLDL. Under the conditions applied, simultaneous addition of 5 µg/mL lipoprotein lipase (LPL) stimulated the cellular uptake and degradation of apoEnull VLDL about 10-fold and resulted in a 5-fold stimulation of the intracellular CE accumulation, from 9±2 to 46±5 µg CE per milligram cell protein. In contrast to control mouse VLDL, apoEnull VLDL could not compete with 125I-labeled LDL for binding to the LDL receptor of J774 cells. Furthermore, neither LDL nor acetylated LDL could compete with 125I-labeled apoEnull VLDL for binding to these cells, whereas control mouse VLDL, VLDL from a hypertriglyceridemic patient, and apoEnull VLDL itself were efficient competitors. Thus, VLDL from apoE-deficient mice is taken up by J774 macrophages through recognition by a distinct receptor, which could be the triglyceride-rich lipoprotein receptor. We conclude that in apoE-deficient mice, foam cell formation occurs via a receptor-mediated uptake of apoEnull VLDL, which can be stimulated by the presence of LPL.


Key Words: apoE-deficient mice • macrophages • foam cells • receptor-mediated uptake • lipoprotein lipase




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M.-D. Wang, R. S. Kiss, V. Franklin, H. M. McBride, S. C. Whitman, and Y. L. Marcel
Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways
J. Lipid Res., March 1, 2007; 48(3): 633 - 645.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Zhao, M. C. de Beer, L. Cai, R. Asmis, F. C. de Beer, W. J.S. de Villiers, and D. R. van der Westhuyzen
Low-Density Lipoprotein From Apolipoprotein E-Deficient Mice Induces Macrophage Lipid Accumulation in a CD36 and Scavenger Receptor Class A-Dependent Manner
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 168 - 173.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. L. Brown, K. Yui, J. D. Smith, R. C. LeBoeuf, W. Weng, P. K. Umeda, R. Li, R. Song, S. H. Gianturco, and W. A. Bradley
The murine macrophage apoB-48 receptor gene (Apob-48r): homology to the human receptor
J. Lipid Res., August 1, 2002; 43(8): 1181 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Marathe, Y. Choi, A. R. Leventhal, and I. Tabas
Sphingomyelinase Converts Lipoproteins From Apolipoprotein E Knockout Mice Into Potent Inducers of Macrophage Foam Cell Formation
Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2607 - 2613.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. D. Medh, G. L. Fry, S. L. Bowen, S. Ruben, H. Wong, and D. A. Chappell
Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism
J. Lipid Res., November 1, 2000; 41(11): 1858 - 1871.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Marathe, G. Kuriakose, K. J. Williams, and I. Tabas
Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix
Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2648 - 2658.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. S. Cohn, C. Marcoux, and J. Davignon
Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins
Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2474 - 2486.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Fujioka, A. D. Cooper, and L. G. Fong
Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages
J. Lipid Res., December 1, 1998; 39(12): 2339 - 2349.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
C. F. Semenkovich, T. Coleman, and A. Daugherty
Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice
J. Lipid Res., June 1, 1998; 39(6): 1141 - 1151.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. J. S. de Villiers, J. D. Smith, M. Miyata, H. M. Dansky, E. Darley, and S. Gordon
Macrophage Phenotype in Mice Deficient in Both Macrophage-Colony–Stimulating Factor (Op) and Apolipoprotein E
Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 631 - 640.
[Abstract] [Full Text] [PDF]